A Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HRS-9821 Powder for Inhalation Administered as a Single Dose in Healthy Participants and Multiple Doses in Patients With COPD

Abroad (travel likely)RecruitingPHASE1

Conditions

COPD

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

West China Hospital, Sichuan University, Chengdu, Sichuan, China
Contact: Principal Investigator (Zhu Luo)
Contact: Principal Investigator (Wei min Li)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Intermittent Intrapulmonary Deflation and Dyspnea Following Exercise in People With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

Abroad (travel likely)Recruiting

Rouen, France

Umbilical Cord Mesenchymal Stem Cells as Adjuvant Therapy in Group E COPD Patients

Chronic Obstructive Pulmonary Disease (COPD)

Abroad (travel likely)RecruitingPHASE2

Jakarta, Indonesia

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Chronic Obstructive Pulmonary Disease (COPD)

Abroad (travel likely)RecruitingPHASE3

Foley, United States · Mobile, United States

Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease

Asthma · COPD · Interstitial Lung Disease

Abroad (travel likely)RecruitingPHASE1

Kansas City, United States